Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
McEvoy JW, Chen Y, Ndumele CE, et al. "Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death." JAMA Cardiol. 2016;1(5):519-28.
Liang J, Le TH, Edwards DRVelez, et al. "Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations." PLoS Genet. 2017;13(5):e1006728.
Deo RC, Wilson JG, Xing C, et al. "Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans." PLoS One. 2011;6(1):e14581.
Morrison AC, Bare LA, Luke MM, et al. "Single nucleotide polymorphisms associated with coronary heart disease predict incident ischemic stroke in the atherosclerosis risk in communities study." Cerebrovasc Dis. 2008;26(4):420-4.
Lu Y, Tang O, Brady TM, et al. "Simplified blood pressure measurement approaches and implications for hypertension screening: the Atherosclerosis Risk in Communities study." J Hypertens. 2020.
Alonso A, Krijthe BP, Aspelund T, et al. "Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium." J Am Heart Assoc. 2013;2(2):e000102.
Rautaharju PM, Prineas RJ, Zhang Z-M. "A simple procedure for estimation of the spatial QRS/T angle from the standard 12-lead electrocardiogram." J Electrocardiol. 2007;40(3):300-4.
Qureshi WT, Zhang Z-M, Chang PP, Rosamond WD, Kitzman DW, Wagenknecht LE. "Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study." J Am Coll Cardiol. 2018;71(1):1-8.
Buxbaum J, Alexander A, Koziol J, Tagoe C, Fox E, Kitzman D. "Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies." Am Heart J. 2010;159(5):864-70.
Bello NA, Hyacinth HI, Roetker NS, et al. "Sickle cell trait is not associated with an increased risk of heart failure or abnormalities of cardiac structure and function." Blood. 2017;129(6):799-801.
Eckfeldt JH, Chambless LE, Shen YL. "Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study." Arch Pathol Lab Med. 1994;118(5):496-500.
Lutsey PL, Parrinello CM, Misialek JR, et al. "Short-term Variability of Vitamin D-Related Biomarkers." Clin Chem. 2016;62(12):1647-1653.
Poon AK, Meyer ML, Reaven G, et al. "Short-Term Repeatability of Insulin Resistance Indexes in Older Adults: The Atherosclerosis Risk in Communities Study." J Clin Endocrinol Metab. 2018;103(6):2175-2181.
Gellert KS, Rautaharju P, Snyder ML, Whitsel EA, Matsushita K, Heiss G. "Short-term repeatability of electrocardiographic Tpeak-Tend and QT intervals." J Electrocardiol. 2014;47(3):356-61.
Vaidean GD, Schroeder EB, Whitsel EA, et al. "Short-term repeatability of electrocardiographic spatial T-wave axis and QT interval." J Electrocardiol. 2005;38(2):139-47.
Meyer ML, Soliman EZ, Drager D. "Short-term repeatability of electrocardiographic criteria of left ventricular hypertrophy." Ann Noninvasive Electrocardiol. 2020;25(2):e12688.
Kim ED, Ballew SH, Tanaka H, Heiss G, Coresh JJ. "Short-Term Prognostic Impact of Arterial Stiffness in Older Adults Without Prevalent Cardiovascular Disease." Hypertension. 2019;74(6):1373-1382.
Chambless LE, McMahon RP, Brown SA, Patsch W, Heiss G, Shen YL. "Short-term intraindividual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Epidemiol. 1992;136(9):1069-81.
Chambless LE, McMahon R, Wu K, Folsom A, Finch A, Shen YL. "Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study." Ann Epidemiol. 1992;2(5):723-33.
Saeed A, Nambi V, Sun W, et al. "Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults." J Am Coll Cardiol. 2018;71(22):2527-2536.
Ma J, Folsom AR, Eckfeldt JH, Lewis L, Chambless LE. "Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Am J Clin Nutr. 1995;62(3):572-8.
Nieto FJ, Diez-Roux A, Szklo M, Comstock GW, Sharrett AR. "Short- and long-term prediction of clinical and subclinical atherosclerosis by traditional risk factors." J Clin Epidemiol. 1999;52(6):559-67.
Dichgans M, Malik R, König IR, et al. "Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants." Stroke. 2014;45(1):24-36.
Malik R, Freilinger T, Winsvold BS, et al. "Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants." Neurology. 2015;84(21):2132-45.
Dastani Z, Johnson T, Kronenberg F, et al. "The shared allelic architecture of adiponectin levels and coronary artery disease." Atherosclerosis. 2013;229(1):145-8.
Prudente S, Copetti M, Morini E, et al. "The SH2B1 obesity locus and abnormal glucose homeostasis: lack of evidence for association from a meta-analysis in individuals of European ancestry." Nutr Metab Cardiovasc Dis. 2013;23(11):1043-9.
Schreiner PJ, Terry JG, Evans GW, Hinson WH, Crouse JR, Heiss G. "Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study." Am J Epidemiol. 1996;144(4):335-45.
Roca GQuerejeta, Redline S, Claggett B, Bello N, Ballantyne CM, Solomon SD. "Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study." Circulation. 2015;132(14):1329-37.
Mongraw-Chaffin ML, Peters SAE, Huxley RR. "The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1·2 million participants." Lancet Diabetes Endocrinol. 2015;3(6):437-449.
Lagou V, Mägi R, Hottenga J-Jan, et al. "Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability." Nat Commun. 2021;12(1):24.
Zhao D, Guallar E, Ballantyne CM, et al. "Sex Hormones and Incident Heart Failure in Men and Postmenopausal Women: The Atherosclerosis Risk in Communities Study." J Clin Endocrinol Metab. 2020;105(10).
George KM, Selvin E, Pankow JS, B Windham G. "Sex Differences in the Association of Diabetes With Cardiovascular Disease Outcomes Among African-American and White Participants in the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2018;187(3):403-410.
Levine DA, Gross AL, Briceño EM, et al. "Sex Differences in Cognitive Decline Among US Adults." JAMA Netw Open. 2021;4(2):e210169.
Davis CE, Williams DH, Oganov RG, et al. "Sex difference in high density lipoprotein cholesterol in six countries." Am J Epidemiol. 1996;143(11):1100-6.
White AD, Rosamond WD, Chambless LE, et al. "Sex and race differences in short-term prognosis after acute coronary heart disease events: the Atherosclerosis Risk In Communities (ARIC) study." Am Heart J. 1999;138(3 Pt 1):540-8.
Vishnu A, Gurka MJ. "The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study." Atherosclerosis. 2015;243(1):278-85.
Echouffo-Tcheugui JB, Daya N, Lee AK, et al. "Severe Hypoglycemia, Cardiac Structure and Function, and Risk of Cardiovascular Events Among Older Adults With Diabetes." Diabetes Care. 2020.
Lee AK, Juraschek SP, B Windham G, Lee CJ, Sharrett ARichey, Coresh JJ. "Severe Hypoglycemia and Risk of Falls in Type 2 Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study." Diabetes Care. 2020;43(9):2060-2065.
Lee AK, McEvoy JW, Hoogeveen RC, Ballantyne CM. "Severe Hypoglycemia and Elevated High-Sensitivity Cardiac Troponin T in Older Adults With Diabetes: The ARIC Study." J Am Coll Cardiol. 2016;68(12):1370-1.
Lee AK, Rawlings AM, Lee CJ, et al. "Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study." Diabetologia. 2018;61(9):1956-1965.
Chambless LE, Cummiskey CP, Cui G. "Several methods to assess improvement in risk prediction models: extension to survival analysis." Stat Med. 2011;30(1):22-38.
Rost NS, Sadaghiani S, Biffi A, et al. "Setting a gold standard for quantification of leukoaraiosis burden in patients with ischemic stroke: the Atherosclerosis Risk in Communities Study." J Neurosci Methods. 2014;221:196-201.
Lu J, Zaimi I, Barber JR, et al. "SES and correlated factors do not explain the association between periodontal disease, edentulism, and cancer risk." Ann Epidemiol. 2019;38:35-41.
Schneider ALC, Zhao D, Lutsey PL, et al. "Serum Vitamin D Concentrations and Cognitive Change Over 20 Years: The Atherosclerosis Risk in Communities Neurocognitive Study." Neuroepidemiology. 2018;51(3-4):131-137.
Faridi KF, Zhao D, Martin SS, et al. "Serum vitamin D and change in lipid levels over 5 y: The Atherosclerosis Risk in Communities study." Nutrition. 2017;38:85-93.
Mellen PB, Bleyer AJ, Erlinger TP, et al. "Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study." Hypertension. 2006;48(6):1037-42.
Kubota Y, McAdams-DeMarco M. "Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study." Thromb Res. 2016;144:144-8.
Hozawa A, Folsom AR, Ibrahim H, Nieto JF, Rosamond WD, Shahar E. "Serum uric acid and risk of ischemic stroke: the ARIC Study." Atherosclerosis. 2006;187(2):401-7.
Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. "Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study." Ann Epidemiol. 2000;10(3):136-43.
Wang A, Barber JR, Tin A, De Marzo AM, Köttgen A, Joshu CE. "Serum Urate, Genetic Variation, and Prostate Cancer Risk: Atherosclerosis Risk in Communities (ARIC) Study." Cancer Epidemiol Biomarkers Prev. 2019;28(7):1259-1261.
Chen G-C, Chai JChoul, Yu B, et al. "Serum sphingolipids and incident diabetes in a US population with high diabetes burden: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)." Am J Clin Nutr. 2020;112(1):57-65.
Lindberg G, Råstam L, Nilsson-Ehle P, et al. "Serum sialic acid and sialoglycoproteins in asymptomatic carotid artery atherosclerosis. ARIC Investigators. Atherosclerosis Risk in Communities." Atherosclerosis. 1999;146(1):65-9.
Lindberg G, Iso H, Råstam L, Lundblad A, Folsom AR. "Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA." Int J Epidemiol. 1997;26(1):58-63.
Chen Y, Chang AR, McAdams DeMarco MA, et al. "Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study." Mayo Clin Proc. 2016;91(10):1403-1412.
Chatterjee R, Yeh H-C, Shafi T, et al. "Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Clin Nutr. 2011;93(5):1087-91.
Alonso A, Yu B, Sun YV, et al. "Serum Metabolomics and Incidence of Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study)." Am J Cardiol. 2019;123(12):1955-1961.
Yu B, Zheng Y, Nettleton JA, Alexander D, Coresh JJ. "Serum metabolomic profiling and incident CKD among African Americans." Clin J Am Soc Nephrol. 2014;9(8):1410-7.
Rebholz CM, Yu B, Zheng Z, et al. "Serum metabolomic profile of incident diabetes." Diabetologia. 2018;61(5):1046-1054.
Menni C, Zhu J, Le Roy CI, et al. "Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes." Gut Microbes. 2020;11(6):1632-1642.
Kim H, Hu EA, Wong KE, et al. "Serum Metabolites Associated with Healthy Diets in African Americans and European Americans." J Nutr. 2021;151(1):40-49.
Lutsey PL, Alonso A, Michos ED, Loehr LR, Astor BC, Coresh JJ. "Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Clin Nutr. 2014;100(3):756-64.
Menez S, Ding N, Grams ME, et al. "Serum magnesium, bone-mineral metabolism markers and their interactions with kidney function on subsequent risk of peripheral artery disease: the Atherosclerosis Risk in Communities Study." Nephrol Dial Transplant. 2020;35(11):1878-1885.
Rooney MR, Alonso A, Folsom AR, et al. "Serum magnesium and the incidence of coronary artery disease over a median 27 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study and a meta-analysis." Am J Clin Nutr. 2020;111(1):52-60.
Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. "Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study." Am Heart J. 2010;160(3):464-70.
Larsson SC, Traylor M, Burgess S, Boncoraglio GB, Jern C, Michaëlsson K. "Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study." Neurology. 2019;92(9):e944-e950.
Rooney MR, Lutsey PL, Alonso A, et al. "Serum magnesium and burden of atrial and ventricular arrhythmias: The Atherosclerosis Risk in Communities (ARIC) Study." J Electrocardiol. 2020;62:20-25.
Rebholz CM, Grams ME, Chen Y, Gross AL, Sang Y, Coresh JJ. "Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease." Am J Epidemiol. 2017;186(8):952-960.
Carnethon MR, Palaniappan LP, Burchfiel CM, Brancati FL, Fortmann SP. "Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: the atherosclerosis risk in communities study: 1987-1998." Diabetes Care. 2002;25(8):1358-64.
Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR. "Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study." Am J Epidemiol. 2002;156(4):349-52.
Tsai AW, Cushman M, Tsai MY, et al. "Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE)." Am J Hematol. 2003;72(3):192-200.
Rebholz CM, Grams ME, Coresh JJ, et al. "Serum fibroblast growth factor-23 is associated with incident kidney disease." J Am Soc Nephrol. 2015;26(1):192-200.
Fyfe-Johnson AL, Alonso A, Selvin E, Bower JK, Pankow JS, Agarwal SK. "Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study." J Hypertens. 2016;34(7):1266-72.
Rooney MR, Pankow JS, Sibley SD, Selvin E, Reis JP, Michos ED. "Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study." Am J Clin Nutr. 2016;104(4):1023-1029.
Chatterjee R, Yeh H-C, Shafi T, et al. "Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study." Arch Intern Med. 2010;170(19):1745-51.
Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. "Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study." Arch Intern Med. 1999;159(18):2151-9.
Misialek JR, Lopez FL, Lutsey PL, et al. "Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans--Atherosclerosis Risk in Communities (ARIC) study." Circ J. 2013;77(2):323-9.
Nelson JJ, Liao D, Sharrett AR, et al. "Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study." Am J Epidemiol. 2000;151(5):468-77.
Shannon CM, Ballew SH, Daya N, et al. "Serum albumin and risks of hospitalization and death: Findings from the Atherosclerosis Risk in Communities study." J Am Geriatr Soc. 2021.
Folsom AR, Lutsey PL, Heckbert SR, Cushman M. "Serum albumin and risk of venous thromboembolism." Thromb Haemost. 2010;104(1):100-4.
Rapson IR, Michos ED, Alonso A, Hirsch AT, Matsushita K, Reis JP. "Serum 25-hydroxyvitamin D is associated with incident peripheral artery disease among white and black adults in the ARIC study cohort." Atherosclerosis. 2017;257:123-129.

Pages